Smartleaf Asset Management LLC Dyne Therapeutics, Inc. Transaction History
Smartleaf Asset Management LLC
- $824 Billion
- Q3 2024
A detailed history of Smartleaf Asset Management LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 45 shares of DYN stock, worth $1,037. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45
Previous 32
40.63%
Holding current value
$1,037
Previous $1.13 Million
34.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DYN
# of Institutions
208Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$185 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$170 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$158 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$157 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$157 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.19B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...